These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5068884)

  • 1. [The clinical and biochemical aspects of clofibrate].
    Ylikahri R; Kähönen M
    Duodecim; 1972; 88(10):688-99. PubMed ID: 5068884
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 3. Data on the treatment of arteriosclerotic and diabetic retinopathy.
    Pék L; Szentirmay K
    Ther Hung; 1974; 22(1):40-3. PubMed ID: 4844932
    [No Abstract]   [Full Text] [Related]  

  • 4. Atromid-S in eye disease.
    Nolan J
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):563-6. PubMed ID: 4534191
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of Clofibrate SPOFA in the treatment of diabetic retinopathy].
    Oláh Z
    Cesk Oftalmol; 1971 Sep; 27(5):315-8. PubMed ID: 5110678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of clofibrate on serum lipid pattern in patients with arteriosclerosis].
    Markiewicz K; Walasek L; Pelka W; Lutz W
    Pol Tyg Lek; 1973 Jul; 28(30):1144-7. PubMed ID: 4732710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversibility of lipid deposition.
    Wolfram G
    Nutr Metab; 1973; 15(1):141-3. PubMed ID: 4711716
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of Clofibrat on plasma lipid levels.
    Szostak WB; Cybulska B; Ruzyllo E
    Mater Med Pol; 1971; 3(4):12-4. PubMed ID: 5162168
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
    Högberg T; Bondesson G; Stjernström NE
    Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1973 Jan; 49(1):31-6. PubMed ID: 4712022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atherosclerosis, hyperlipidemia and clofibrate].
    Eisenberg S; Stein Y
    Harefuah; 1979 Jun; 96(12):677-8. PubMed ID: 520921
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of clofibrate on glucose tolerance in patients with coronary heart disease.
    Ruzyllo E; Szostak WB; Cybulska B
    Pol Arch Med Wewn; 1972 Feb; 49(2):121-3. PubMed ID: 4670209
    [No Abstract]   [Full Text] [Related]  

  • 14. [New aspects of the therapy of arteriosclerosis].
    Avogaro P; Capri C; Cazzolato G
    Recenti Prog Med; 1971 Nov; 51(5):455-70. PubMed ID: 5172398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clofibrate in the treatment of diabetic retinopathy].
    Rjasanowski J; Bruns W
    Vestn Oftalmol; 1979; (2):45-8. PubMed ID: 373211
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of atromide-S in the treatment of diabetic retinopathy].
    Kliachko VR; Tirkina TN; Aleksandrova LM; Mazovetskiĭ AG
    Sov Med; 1973 Dec; 36(12):59-61. PubMed ID: 4779364
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs which decrease serum lipids].
    Oye I
    Tidsskr Nor Laegeforen; 1973 Jan; 93(1):32-3. PubMed ID: 4691222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes of the humoral lipid picture in arteriosclerotis subjects treated with clofibrate].
    Notarbartolo A; Rini GB; Di Fede G
    Boll Soc Ital Cardiol; 1973; 18(4):384-94. PubMed ID: 4807079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.